-0.000115891268236737 -0.000437811457783395 -0.0024095726187564 -0.0030534129978496 -0.00345581323478284 -0.00116213188426329 -0.00067925159994336 -0.00148405207380983
Sign Up Today X
Thanks for submitting the form.
Stockreport

3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026 [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
The index bottomed out in April 2025 on potential imposition of steep tariffs, which weighed heavily on the broader pharma and biotech sector. Nonetheless, the recovery thereafter has been stupendous. New drug approvals, positive pipeline and regulatory updates, and a surge in mergers and acquisitions (M&A) activity have propelled the rally. The FDA has approved more than 42 drugs year to date. The year has also witnessed a surge in M&A activity, fueled by the changing landscape and the spotlight on AI-driven drug discovery. Quite a few of the large pharmaceutical and biotechnology bigwigs are looking to expand/diversify their product portfolios through strategic collaborations and acquisitions to adapt their business models amid rising generic competition for key drugs. Meanwhile, the Trump administration recently signed agreements with major pharma/biotech bigwigs like Gilead Sciences, Amgen, Merck and Novartis, among others, to lower prescription drug prices for Americans. Th [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026 [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
The index bottomed out in April 2025 on potential imposition of steep tariffs, which weighed heavily on the broader pharma and biotech sector. Nonetheless, the recovery thereafter has been stupendous. New drug approvals, positive pipeline and regulatory updates, and a surge in mergers and acquisitions (M&A) activity have propelled the rally. The FDA has approved more than 42 drugs year to date. The year has also witnessed a surge in M&A activity, fueled by the changing landscape and the spotlight on AI-driven drug discovery. Quite a few of the large pharmaceutical and biotechnology bigwigs are looking to expand/diversify their product portfolios through strategic collaborations and acquisitions to adapt their business models amid rising generic competition for key drugs. Meanwhile, the Trump administration recently signed agreements with major pharma/biotech bigwigs like Gilead Sciences, Amgen, Merck and Novartis, among others, to lower prescription drug prices for Americans. Th [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS